MWM
ABBV icon

Marion Wealth Management’s AbbVie ABBV Stock Holding History

Marion Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,381
Closed -$423K – 129
2024
Q4 		$423K Buy
2,381
+1
+0% +$184 0.11% 94
2024
Q3 		$470K Buy
2,380
+1
+0% +$187 0.13% 93
2024
Q2 		$408K Sell
2,379
-374
-14% -$62K 0.12% 93
2024
Q1 		$501K Sell
2,753
-9
-0.3% -$1.55K 0.15% 88
2023
Q4 		$428K Sell
2,762
-690
-20% -$101K 0.14% 89
2023
Q3 		$515K Buy
3,452
+1,085
+46% +$159K 0.18% 84
2023
Q2 		$319K Buy
2,367
+10
+0.4% +$1.47K 0.11% 91
2023
Q1 		$376K Buy
+2,357
New +$360K 0.14% 87

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Marion Wealth Management's ABBV Position: Q1 2025 in Review

Marion Wealth Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 2,381 shares — an estimated $423K sold.

Marion Wealth Management first reported a position in ABBV in Q1 2023 and held it in 8 quarters. The position peaked at $515K in Q3 2023. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Marion Wealth Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Marion Wealth Management sold 2,381 AbbVie shares in Q1 2025, an estimated $423K.
  • Marion Wealth Management first reported a position in AbbVie in Q1 2023 and held it in 8 quarters.
  • Marion Wealth Management's AbbVie position peaked at $515K in Q3 2023.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Marion Wealth Management's 13F filing for Q1 2025, filed 8 Apr 2025.